{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:26:14Z","timestamp":1740108374797,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1038\/s10038-022-01014-3","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T01:02:36Z","timestamp":1641949356000},"page":"339-345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Increased incidence of pathogenic variants in ATM in the context of testing for breast and ovarian cancer predisposition"],"prefix":"10.1038","volume":"67","author":[{"given":"P.","family":"Macquere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Orazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Bubien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Chiron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lafon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Barouk-Simonet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Tinat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Venat-Bouvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Longy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4924-4279","authenticated-orcid":false,"given":"N.","family":"Sevenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"key":"1014_CR1","doi-asserted-by":"publisher","first-page":"104350","DOI":"10.1016\/j.ejmg.2021.104350","volume":"64","author":"DH Marmolejo","year":"2021","unstructured":"Marmolejo DH, Zheng Wong MY, Bajalica-Lagercrantz S, Tischkowitz M, Balma\u00f1a J, Pat\u00f3cs AB, et al. Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe. Eur J Med Genet. 2021;64:104350.","journal-title":"Eur J Med Genet"},{"key":"1014_CR2","doi-asserted-by":"publisher","first-page":"12629","DOI":"10.1073\/pnas.1007983107","volume":"107","author":"T Walsh","year":"2010","unstructured":"Walsh T, Lee MK, Casadei S, Thornton AM, Stray SM, Pennil C, et al. Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci USA. 2010;107:12629\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1014_CR3","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF, Pharoah PDP, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, et al. Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 2015;372:2243\u201357.","journal-title":"N Engl J Med"},{"key":"1014_CR4","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.bulcan.2018.08.003","volume":"105","author":"J Moretta","year":"2018","unstructured":"Moretta J, Berthet P, Bonadona V, Caron O, Cohen-Haguenauer O, Colas C, et al. The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition. Bull Cancer. 2018;105:907\u201317.","journal-title":"Bull Cancer"},{"key":"1014_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ejhg.2015.226","volume":"24","author":"G Matthijs","year":"2016","unstructured":"Matthijs G, Souche E, Alders M, Corveleyn A, Eck S, Feenstra I, et al. Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet. 2016;24:2\u20135.","journal-title":"Eur J Hum Genet."},{"key":"1014_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The ensembl variant effect predictor. Genome Biol. 2016;17:122.","journal-title":"Genome Biol."},{"key":"1014_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med."},{"key":"1014_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-1-60761-759-4_14","volume":"653","author":"GR Evans","year":"2010","unstructured":"Evans GR, Lalloo F. Development of a scoring system to screen for BRCA1\/2 mutations. Methods Mol Biol. 2010;653:237\u201347.","journal-title":"Methods Mol Biol."},{"key":"1014_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/jmedgenet-2017-105073","volume":"55","author":"W Chew","year":"2018","unstructured":"Chew W, Moorakonda RB, Courtney E, Soh H, Li ST, Chen Y, et al. Evaluation of the relative effectiveness of the 2017 updated Manchester scoring system for predicting BRCA1\/2 mutations in a Southeast Asian country. J Med Genet. 2018;55:344\u201350.","journal-title":"J Med Genet"},{"key":"1014_CR10","unstructured":"FLOSSIES - A database of germline genomic variation in healthy older women. FLOSSIES. https:\/\/whi.color.com\/"},{"key":"1014_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Genome Aggregation Database Consortium, Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434\u201343.","journal-title":"Nature"},{"key":"1014_CR12","unstructured":"Mangiafico S rcompanion: functions to support extension education program evaluation. 2020. https:\/\/CRAN.R-project.org\/package=rcompanion."},{"key":"1014_CR13","unstructured":"Exact Analysis of Discrete Data. Routledge & CRC Press. https:\/\/www.routledge.com\/Exact-Analysis-of-Discrete-Data\/Hirji\/p\/book\/9781584880707."},{"key":"1014_CR14","unstructured":"Practical Guide to Cluster Analysis in R. Datanovia. https:\/\/www.datanovia.com\/en\/product\/practical-guide-to-cluster-analysis-in-r\/."},{"key":"1014_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v025.i01","volume":"25","author":"S L\u00ea","year":"2008","unstructured":"L\u00ea S, Josse J, Husson F. FactoMineR: an R package for multivariate analysis. J Stat Softw. 2008;25:1\u201318.","journal-title":"J Stat Softw"},{"key":"1014_CR16","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.18632\/oncotarget.12699","volume":"8","author":"M Eliade","year":"2017","unstructured":"Eliade M, Skrzypski J, Baurand A, Jacquot C, Bertolone G, Loustalot C, et al. The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families? Oncotarget. 2017;8:1957\u201371.","journal-title":"Oncotarget."},{"key":"1014_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ijc.30428","volume":"140","author":"C Kraus","year":"2017","unstructured":"Kraus C, Hoyer J, Vasileiou G, Wunderle M, Lux MP, Fasching PA, et al. Gene panel sequencing in familial breast\/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1\/2. Int J Cancer. 2017;140:95\u2013102.","journal-title":"Int J Cancer"},{"key":"1014_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.29010","volume":"121","author":"N Tung","year":"2015","unstructured":"Tung N, Battelli C, Allen B, Kaldate R, Bhatnagar S, Bowles K, et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer. 2015;121:25\u201333.","journal-title":"Cancer."},{"key":"1014_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/wics.101","volume":"2","author":"H Abdi","year":"2010","unstructured":"Abdi H, Williams LJ. Principal component analysis. WIREs Comput Stat. 2010;2:433\u201359.","journal-title":"WIREs Comput Stat"},{"key":"1014_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylk\u00e4s K, Roberts J, et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;371:497\u2013506.","journal-title":"N Engl J Med"},{"key":"1014_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1158\/2159-8290.CD-11-0194","volume":"2","author":"NJ Roberts","year":"2012","unstructured":"Roberts NJ, Jiao Y, Yu J, Kopelovich L, Petersen GM, Bondy ML, et al. ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov 2012;2:41\u20136.","journal-title":"Cancer Discov"},{"key":"1014_CR22","unstructured":"ONCOG\u00c9N\u00c9TIQUE EN 2019 \/consultations & laboratoires. Collection Appui \u00e0 la d\u00e9cision. https:\/\/www.e-cancer.fr\/content\/download\/315909\/4525311\/file\/Oncoge%CC%81ne%CC%81tique%20en%202019%20-%20Consultations,%20laboratoires%20et%20suivi_MeL_20210624.pdf"},{"key":"1014_CR23","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","volume":"22","author":"L Cast\u00e9ra","year":"2014","unstructured":"Cast\u00e9ra L, Krieger S, Rousselin A, Legros A, Baumann J-J, Bruet O, et al. Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur J Hum Genet. 2014;22:1305\u201313.","journal-title":"Eur J Hum Genet."},{"key":"1014_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3343\/alm.2020.40.2.148","volume":"40","author":"J Yoo","year":"2020","unstructured":"Yoo J, Lee GD, Kim JH, Lee SN, Chae H, Han E, et al. Clinical validity of next-generation sequencing multi-gene panel testing for detecting pathogenic variants in patients with hereditary breast-ovarian cancer syndrome. Ann Lab Med. 2020;40:148\u201354.","journal-title":"Ann Lab Med"},{"key":"1014_CR25","doi-asserted-by":"publisher","first-page":"697","DOI":"10.4143\/crt.2019.559","volume":"52","author":"H-C Shin","year":"2020","unstructured":"Shin H-C, Lee H-B, Yoo T-K, Lee E-S, Kim RN, Park B, et al. Detection of germline mutations in breast cancer patients with clinical features of hereditary cancer syndrome using a multi-gene panel test. Cancer Res Treat. 2020;52:697\u2013713.","journal-title":"Cancer Res Treat."},{"key":"1014_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10897-016-9985-2","volume":"26","author":"AE Bunnell","year":"2017","unstructured":"Bunnell AE, Garby CA, Pearson EJ, Walker SA, Panos LE, Blum JL. The clinical utility of next generation sequencing results in a community-based hereditary cancer risk program. J Genet Couns. 2017;26:105\u201312.","journal-title":"J Genet Couns."},{"key":"1014_CR27","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 2017;3:1190\u20136.","journal-title":"JAMA Oncol."},{"key":"1014_CR28","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/s41436-018-0005-9","volume":"20","author":"L Cast\u00e9ra","year":"2018","unstructured":"French Exome Project Consortium, Cast\u00e9ra L, Harter V, Muller E, Krieger S, Goardon N, et al. Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families. Genet Med. 2018;20:1677\u201386.","journal-title":"Genet Med."},{"key":"1014_CR29","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1200\/JCO.19.01907","volume":"38","author":"X Yang","year":"2020","unstructured":"Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B, et al. Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families. J Clin Oncol. 2020;38:674\u201385.","journal-title":"J Clin Oncol."},{"key":"1014_CR30","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 2017;3:1190\u20136.","journal-title":"JAMA Oncol."},{"key":"1014_CR31","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/sj.bjc.6690460","volume":"80","author":"N Janin","year":"1999","unstructured":"Janin N, Andrieu N, Ossian K, Laug\u00e9 A, Croquette MF, Griscelli C, et al. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. Br J Cancer. 1999;80:1042\u20135.","journal-title":"Br J Cancer"},{"key":"1014_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.cancergen.2015.06.001","volume":"208","author":"F Aloraifi","year":"2015","unstructured":"Aloraifi F, McCartan D, McDevitt T, Green AJ, Bracken A, Geraghty J. Protein-truncating variants in moderate-risk breast cancer susceptibility genes: a meta-analysis of high-risk case-control screening studies. Cancer Genet. 2015;208:455\u201363.","journal-title":"Cancer Genet."},{"key":"1014_CR33","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/ng1837","volume":"38","author":"A Renwick","year":"2006","unstructured":"Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet. 2006;38:873\u20135.","journal-title":"Nat Genet."},{"key":"1014_CR34","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.7314\/APJCP.2012.13.7.3501","volume":"13","author":"Y Yang","year":"2012","unstructured":"Yang Y, Zhang F, Wang Y, Liu S-C. CHEK2 1100delC variant and breast cancer risk in Caucasians: a meta-analysis based on 25 studies with 29,154 cases and 37,064 controls. Asian Pac J Cancer Prev. 2012;13:3501\u20135.","journal-title":"Asian Pac J Cancer Prev."},{"key":"1014_CR35","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa2005936","volume":"384","author":"C Hu","year":"2021","unstructured":"Hu C, Hart SN, Gnanaolivu R, Huang H, Lee KY, Na J, et al. A population-based study of genes previously implicated in breast cancer. N Engl J Med. 2021;384:440\u201351.","journal-title":"N Engl J Med"},{"key":"1014_CR36","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","volume":"384","author":"L Dorling","year":"2021","unstructured":"Breast Cancer Association Consortium, Dorling L, Carvalho S, Allen J, Gonz\u00e1lez-Neira A, Luccarini C, et al. Breast cancer risk genes - association analysis in more than 113,000 women. N Engl J Med 2021;384:428\u201339.","journal-title":"N Engl J Med"},{"key":"1014_CR37","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1200\/JCO.20.01992","volume":"39","author":"C Gao","year":"2021","unstructured":"Gao C, Polley EC, Hart SN, Huang H, Hu C, Gnanaolivu R, et al. Risk of breast cancer among carriers of pathogenic variants in breast cancer predisposition genes varies by polygenic risk score. J Clin Oncol. 2021;39:2564\u201373.","journal-title":"J Clin Oncol."},{"key":"1014_CR38","doi-asserted-by":"publisher","first-page":"djw302","DOI":"10.1093\/jnci\/djw302","volume":"109","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, McGuffog L, Barrowdale D, Lee A, Soucy P, Dennis J, et al. Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2017;109:djw302.","journal-title":"J Natl Cancer Inst"},{"key":"1014_CR39","doi-asserted-by":"publisher","first-page":"djv036","DOI":"10.1093\/jnci\/djv036","volume":"107","author":"N Mavaddat","year":"2015","unstructured":"Mavaddat N, Pharoah PDP, Michailidou K, Tyrer J, Brook MN, Bolla MK, et al. Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst. 2015;107:djv036.","journal-title":"J Natl Cancer Inst"},{"key":"1014_CR40","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/cancers12030687","volume":"12","author":"NR Jette","year":"2020","unstructured":"Jette NR, Kumar M, Radhamani S, Arthur G, Goutam S, Yip S, et al. ATM-deficient cancers provide new opportunities for precision oncology. Cancers. 2020;12:687.","journal-title":"Cancers."},{"key":"1014_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1756-9966-32-95","volume":"32","author":"MS Gilardini Montani","year":"2013","unstructured":"Gilardini Montani MS, Prodosmo A, Stagni V, Merli D, Monteonofrio L, Gatti V, et al. ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition. J Exp Clin Cancer Res. 2013;32:95.","journal-title":"J Exp Clin Cancer Res."},{"key":"1014_CR42","doi-asserted-by":"publisher","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","volume":"66","author":"N McCabe","year":"2006","unstructured":"McCabe N, Turner NC, Lord CJ, Kluzek K, Bialkowska A, Swift S, et al. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res. 2006;66:8109\u201315.","journal-title":"Cancer Res."}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-022-01014-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-022-01014-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-022-01014-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T23:05:18Z","timestamp":1653433518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-022-01014-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1014"],"URL":"https:\/\/doi.org\/10.1038\/s10038-022-01014-3","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"type":"print","value":"1434-5161"},{"type":"electronic","value":"1435-232X"}],"subject":[],"published":{"date-parts":[[2022,1,12]]},"assertion":[{"value":"2 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}